Atlas Trials

Serum Glycomics as Prognostic and Diagnostic Biomarkers of Disease Recurrence in Liver Transplant Recipients With Hepatocellular Carcinoma

Clinical trial NCT05866783 · RECRUITING

Trial details

NCT number
NCT05866783
Sponsor
University Hospital, Ghent
Status
RECRUITING
Study type
OBSERVATIONAL
Prognostic BiomarkerLiver TransplantationDiagnostic BiomarkerHepatocellular Carcinoma
Start date
2023-04-28
Primary completion
2027-01-01
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.